AstraZeneca PLC (LON:0A4J)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,230	5,488	5,840	6,166	6,329	7,832
Short-Term Investments	165	-	-	64	53	42
Trading Asset Securities	-	37	20	14	16	161
Cash & Short-Term Investments	5,395	5,525	5,860	6,244	6,398	8,035
Cash Growth	-32.74%	-5.72%	-6.15%	-2.41%	-20.37%	29.22%
Accounts Receivable	13,250	8,302	8,407	7,212	6,031	3,806
Other Receivables	1,565	4,792	3,528	2,711	2,764	1,845
Receivables	14,815	13,094	11,935	9,923	8,795	5,651
Inventory	5,884	5,288	5,424	4,699	8,983	4,024
Prepaid Expenses	-	1,737	1,617	1,329	1,512	1,735
Restricted Cash	-	129	102	162	-	-
Other Current Assets	45	54	116	236	556	99
Total Current Assets	26,139	25,827	25,054	22,593	26,244	19,544
Property, Plant & Equipment	12,303	11,647	10,502	9,449	10,171	8,917
Long-Term Investments	1,900	1,900	1,677	1,142	1,262	1,192
Goodwill	21,130	21,025	20,048	19,820	19,997	11,845
Other Intangible Assets	37,550	37,177	38,089	39,307	42,387	20,947
Long-Term Deferred Tax Assets	6,095	5,347	4,718	3,263	4,330	3,438
Other Long-Term Assets	1,136	1,112	1,031	909	972	846
Total Assets	106,253	104,035	101,119	96,483	105,363	66,729
Accounts Payable	22,544	3,640	3,267	2,550	2,824	2,350
Accrued Expenses	-	16,088	15,845	13,514	12,358	9,689
Short-Term Debt	-	330	515	350	411	661
Current Portion of Long-Term Debt	3,425	2,057	5,603	5,924	2,248	1,566
Current Portion of Leases	355	339	271	228	233	192
Current Income Taxes Payable	1,656	1,406	1,584	896	916	1,127
Current Unearned Revenue	-	126	149	182	1,181	1,958
Other Current Liabilities	1,149	3,880	3,308	2,649	2,423	2,764
Total Current Liabilities	29,129	27,866	30,542	26,293	22,594	20,307
Long-Term Debt	26,741	26,621	22,403	23,908	29,717	19,804
Long-Term Leases	1,196	1,113	857	725	754	489
Long-Term Unearned Revenue	-	-	7	14	26	38
Long-Term Deferred Tax Liabilities	3,553	3,305	2,844	2,944	6,206	2,918
Other Long-Term Liabilities	3,224	2,929	3,780	4,373	4,325	4,333
Total Liabilities	65,122	63,164	61,953	59,425	66,076	51,091
Common Stock	388	388	388	387	387	328
Additional Paid-In Capital	35,233	35,226	35,188	35,155	35,126	7,971
Retained Earnings	3,364	7,229	4,516	3,120	3,644	6,442
Comprehensive Income & Other	2,054	-2,057	-949	-1,625	111	881
Total Common Equity	41,039	40,786	39,143	37,037	39,268	15,622
Minority Interest	92	85	23	21	19	16
Shareholders' Equity	41,131	40,871	39,166	37,058	39,287	15,638
Total Liabilities & Equity	106,253	104,035	101,119	96,483	105,363	66,729
Total Debt	31,717	30,460	29,649	31,135	33,363	22,712
Net Cash (Debt)	-26,322	-24,935	-23,789	-24,891	-26,965	-14,677
Net Cash Per Share	-16.84	-15.95	-15.23	-15.96	-18.90	-11.18
Filing Date Shares Outstanding	1,550	1,551	1,550	1,550	1,549	1,313
Total Common Shares Outstanding	1,550	1,551	1,550	1,550	1,549	1,313
Working Capital	-2,990	-2,039	-5,488	-3,700	3,650	-763
Book Value Per Share	26.48	26.30	25.25	23.90	25.34	11.90
Tangible Book Value	-17,641	-17,416	-18,994	-22,090	-23,116	-17,170
Tangible Book Value Per Share	-11.38	-11.23	-12.25	-14.25	-14.92	-13.08
Land	-	6,580	6,469	5,440	6,377	5,851
Machinery	-	8,854	8,704	7,556	7,903	7,738
Construction In Progress	-	2,789	2,045	2,653	2,728	2,478

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.